Inferred immune-cell activity is an independent predictor of HER2-negative breast cancer prognosis and response to paclitaxel-based therapy in the GeparSepto trial - Fasching, Peter Andreas; Szeto, Christopher; Denkert, Carsten; Benz, Stephen; Weber, Karsten; Spilman, Patricia; Budczies, Jan; Schneeweiss, Andreas; Stickeler, Elmar; Schmatloch, Sabine; Jackisch, Christian; Karn, Thomas; et al. (Clinical cancer research, 2023)
Veröffentlicht: 05. Juli 2023